Cyclin D1 Overexpression, p16 Loss, and pRb Inactivation Play a Key Role in Pulmonary Carcinogenesis and have a Prognostic Implication for the Long-term Survival in Non-small Cell Lung Carcinoma Patients
Author:
Open Access
- 1 January 2008
- journal article
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 40 (2) , 45-52
Abstract
Myong NH. Cancer Res Treat. 2008 Jun;40(2):45-52. http://dx.doi.org/10.4143/crt.2008.40.2.45Keywords
This publication has 25 references indexed in Scilit:
- Prognostic implications of cell cycle‐related proteins in primary resectable pathologic N2 nonsmall cell lung cancerCancer, 2007
- Prognostic Implications of Cell Cycle, Apoptosis, and Angiogenesis Biomarkers in Non–Small Cell Lung Cancer: A ReviewClinical Cancer Research, 2005
- Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanomaLaboratory Investigation, 2005
- Prognostic Implications of Molecular and Immunohistochemical Profiles of the Rb and p53 Cell Cycle Regulatory Pathways in Primary Non–Small Cell Lung CarcinomaClinical Cancer Research, 2005
- The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancerLung Cancer, 2003
- RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancerOncogene, 2002
- Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancerInternational Journal of Cancer, 1998
- Cancer Cell CyclesScience, 1996
- Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer.Proceedings of the National Academy of Sciences, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993